Pharmaceutical industry is divided into pharmaceutical manufacturing and pharmaceutical business, medicine, chemical raw materials manufacturing industry broken down into manufacturing, chemical manufacturing, medicine manufacturing, processing of Chinese Herbal Medicine, biological and biochemical products manufacturing and sanitation materials and medical supplies manufacturing categories. Among them, chemical pharmaceutical raw materials manufacturing, chemical manufacturing are chemical and pharmaceutical industries.

Chemical and pharmaceutical industry is the basic chemical industry, fine chemical industry, downstream industries. Complete chemical and pharmaceutical production value chain from basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and production processes such as chemical agents pose.

Among them, chemical raw materials for the production of chemical agents is the main raw material, mainly prepared by chemical synthesis of active pharmaceutical ingredients, but the patient still can not directly use glutathione drugs still are further processed, that is preparation. API pharmaceutical intermediates during the production of intermediate products. At this stage the major domestic manufacturers of pharmaceutical intermediates, pharmaceutical Jincheng, Boqi chemical so few.

In 2009, China chemical raw materials industry, sales of 1,956 billion yuan, accounting for sales of the pharmaceutical industry 21.59%, in the pharmaceutical sub-sector in the second. In addition, chia seed chemical raw materials is China's largest export pharmaceutical products, but also China's most internationally competitive industrial areas.

Chinese API industry enterprises in the domestic pharmaceutical industry and exports play an important role, in the international market also played an increasingly influential.

In the global API market, in addition to the formation of a certain drug patent monopolies of raw materials supply and demand structure, the chemical raw materials market is a perfectly competitive market. Meanwhile, with the global pharmaceutical industry, resveratrol generic drugs and raw materials consumption increased the proportion of the transfer of the pattern of drug production, international agents to take more and more companies outsource manufacturing bulk drugs, drug raw materials from developing countries, manufacturers and vendors purchasing agents needed for the production of bulk drugs. In the global bulk drug market under the influence of these trends, China, India, Brazil and Russia as the representative of a growing number of emerging markets bulk drugs and formulations bulk drugs manufacturers to participate in the international supply and demand system.

Generic API in single-species specific market segments, due to raw material resources, economies of scale, plant extracts technological advantages and other factors may still cause a degree of monopolistic competition or oligopolistic competition. However, due to the global generics and bulk drugs is highly competitive, generic drug manufacturers and their raw materials are required to prevent the entry of potential competitors, does not have continuous, high monopoly pricing.

As the world's largest raw material medicine production and export country, China's raw material drug docetaxel companies producing and marketing major has been fully integrated into the international market system, not only ready to face competition from other domestic companies, but also bear the bulk drugs abroad, especially in India the pressure of competition between similar products companies, it faces the constant increase in the market, competition is intensifying. Source:www.cospcn.com